Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

Synthetic Cannabinoids in Teens: What Clinicians Should Know

French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.

Why Does the Heart Rarely Develop Cancer?

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

Inpatient Rehab Underutilized After Stroke, TBI

Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.

New Vericiguat Analysis Shows Hidden Benefits in HF

Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.

Menopause Age Linked to Higher Hypercholesterolaemia Burden

Women experience a significant increase in hypercholesterolaemia diagnoses and related comorbidities around the menopausal transition compared with men.

Early Treatment Cuts Heart Risk in Hypercholesterolaemia

Early treatment of FH in childhood and adolescence may reduce lifetime cholesterol burden and lower the cardiovascular risk compared to treatment starting later in adulthood.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.

Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.

Women experience a significant increase in hypercholesterolaemia diagnoses and related comorbidities around the menopausal transition compared with men.

Early treatment of FH in childhood and adolescence may reduce lifetime cholesterol burden and lower the cardiovascular risk compared to treatment starting later in adulthood.

News All Time

Phase 3 HCM Drug Offers Promising Results in Exercise Tests

Treatment with aficamten may improve multiple measures of exercise in patients with obstructive hypertrophic cardiomyopathy, a study finds.

Early Pregnancy Thyroid Issues Signal Later Hypothyroidism

Thyroid abnormalities in early pregnancy are associated with an increased risk of developing hypothyroidism later in life.

Will Genomics Move From Innovation to Routine Care?

Pharmacogenomics and polygenic risk scores could replace trial-and-error prescribing — but workflow, trust, and equity stand in the way.

GLP-1 Therapy: Can a Myostatin Antibody Preserve Muscle?

A phase 2 trial suggests myostatin inhibition may reduce lean body mass loss during tirzepatide treatment while maintaining overall weight reduction.

How Extreme Heat Threatens Athlete Safety

High temperatures, humidity, and prolonged exertion can overwhelm the body’s cooling systems. Here’s what clinicians should know about heat risk in sport.

Europe’s Liver Crisis Is Hidden in Plain Sight

Alcohol, ultraprocessed food, and undetected hepatitis are fueling a quiet liver crisis across Europe; researchers say earlier action could prevent millions of premature deaths.

Early Weight Loss in T2D Tied to Fewer Vascular Events

Achieving at least 15% weight loss within 2 years of a T2D diagnosis is linked to lower risks for macrovascular and microvascular complications than maintaining a stable weight.

Shorter Romosozumab Course Works as Well as 12-Month Regimen

A 3-month course of romosozumab followed by denosumab produced bone density gains comparable to those of the standard 12-month regimen in postmenopausal women at high fracture risk.

Hypotension Emerges as Top CVD Factor Linked to AD

Among multiple cardiovascular disease subtypes examined in two large cohorts, hypotension shows the strongest association with Alzheimer’s disease.

Treatment Timing May Affect Serum Urate Control in Gout

In patients with gout, the late initiation of urate-lowering therapy is linked to poorer long-term serum urate control, and better treatment adherence is linked to improved control.

5 Critical Mistakes Doctors Make in Managing CKM

As cardiovascular-kidney-metabolic syndrome becomes increasingly adopted, physicians are faced with the challenge of overcoming old, siloed habits.

QFR-Guided PCI Linked to Improved Long-Term Outcomes

Patients undergoing quantitative flow ratio-guided PCI had fewer major adverse cardiac events over 5 years than those treated with angiography-guided PCI.

Could Dedicated Women’s Heart Centers Close Care Gaps?

Experts call for more women’s Heart Centers across Europe, citing persistent disparities in cardiovascular diagnosis, treatment, and outcomes.

Left Main CAD: Can New 10-Year Data Settle the Debate?

Ten-year follow-up data show similar mortality with PCI and CABG in selected patients, adding new evidence to the long-standing revascularization debate.

What Anxiety and Depression Signal in Atrial Fibrillation

Anxiety and depression are linked to a higher risk for death and major adverse cardiovascular events, with a greater risk at higher symptom severity, prompting closer attention in routine care.

Finerenone May Cut Sudden Death Risk Across the CKM Spectrum

Finerenone treatment is associated with a reduced risk for sudden death among adults with chronic kidney disease, type 2 diabetes, or heart failure, study finds.

Recommended News For You

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

Leukemia cells evade treatment by reshaping their mitochondria, researchers discover

Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.

De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer

Fear of hair loss might cause some to reject cancer treatment

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

What Do Patients Want Doctors to Know About Breast Cancer Recurrence?

Recommended Articles For You

Targeting Oncology: Expanding Combinatorial Strategies by 2025 

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment 

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More  

The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

2.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

3.

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

4.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

5.

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

1.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

2.

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review

3.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

4.

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies

5.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Navigating the Complexities of Ph Negative ALL - Part XI

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot